TETRALOGIC PHARMACEUTICALS CORP 4
4 · TETRALOGIC PHARMACEUTICALS CORP · Filed Jan 30, 2015
Insider Transaction Report
Form 4
Meyers Peter A.
CFO & Treasurer
Transactions
- Award
Restricted Stock Unit
2015-01-28+75,000→ 0 totalExp: 2018-01-28→ Common Stock (75,000 underlying) - Award
Stock Option
2015-01-28$5.25/sh+100,000$525,000→ 611,195 totalExercise: $5.25Exp: 2025-01-28→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Beginning January 28, 2015, stock options will vest and become exercisable at 2% per month until fully vested. Stock options are subject to the reporting person's continued service as of each vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of TetraLogic Pharmaceuticals Corporation common stock. All 75,000 restricted stock units shall vest on January 28, 2018. Restricted stock units are subject to the reporting person's continued service as of the vesting date.